Title : [Basal insulin glargine-lixisenatide fixed ratio combination (Suliqua®)].

Pub. Date : 2019 Feb

PMID : 30793566






3 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 [Basal insulin glargine-lixisenatide fixed ratio combination (Suliqua )]. Insulin Glargine insulin Homo sapiens
2 Both molecules exert complementary antihyperglycaemic effects : insulin glargine mainly targets fasting glycaemia while lixisenatide mainly targets postprandial hyperglycaemia. Insulin Glargine insulin Homo sapiens
3 It has a good tolerance profile, with a more favourable effect on body weight compared with insulin glargine alone and less gastrointestinal adverse effects when compared with lixisenatide alone, because of a more progressive titration of the GLP-1 receptor agonist component. Insulin Glargine insulin Homo sapiens